These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23098867)

  • 1. Physicians' prescribing patterns for patients with diabetes are changing for the better.
    Rodbard HW; Jellinger PS
    Am J Med; 2012 Nov; 125(11):e11-2. PubMed ID: 23098867
    [No Abstract]   [Full Text] [Related]  

  • 2. HbA1C, finding the right target in 2018.
    Vela D
    Diabetes Metab Syndr; 2018 Jul; 12(4):607-608. PubMed ID: 29622471
    [No Abstract]   [Full Text] [Related]  

  • 3. Do cost containment policies save money and influence physicians' prescribing behavior? Lessons from South Korea's drug policy for diabetes medication.
    Kang SO; Kim SJ; Park S; Jang SI; Park EC
    Int J Qual Health Care; 2019 Mar; 31(2):96-102. PubMed ID: 29788203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are there any differences in the management of diabetes mellitus 2 in complex chronic patients compared to non-complex ones?].
    Beà M; Formiga F
    Semergen; 2019 Apr; 45(3):208-210. PubMed ID: 30573366
    [No Abstract]   [Full Text] [Related]  

  • 5. Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008.
    Currie CJ; Peters JR; Evans M
    Diabet Med; 2010 Jul; 27(7):744-52. PubMed ID: 20636954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological multicentre study on the education provided to patients with type 2 diabetes mellitus in the Spanish Health Care System. The Forma2 study.
    García-Donaire JA; Franch-Nadal J; Rodríguez-Fortúnez P; Labrador-Barba E; Orera-Peña ML; Rodríguez de Miguel M
    Semergen; 2018; 44(1):5-12. PubMed ID: 28511878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. India: Doctors report surge in use of off label GLP-1 agonists among rich.
    Lal N
    BMJ; 2024 Jul; 386():q1605. PubMed ID: 39029939
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation.
    Mehta SN; Goldfine AB; Abrahamson MJ; DiVincenzo R; Laffel LM
    J Diabetes Sci Technol; 2013 Jan; 7(1):119-22. PubMed ID: 23439167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing in type 2 diabetes: choices and challenges.
    Hill J
    Nurs Stand; 2010 Oct 6-12; 25(5):55-6, 58. PubMed ID: 21133019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Diabetes Care Providers Too Glucocentric?
    Lau DC
    Can J Diabetes; 2016 Dec; 40(6):479-481. PubMed ID: 27810227
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.
    Geier AS; Wellmann I; Wellmann J; Kajüter H; Heidinger O; Hempel G; Hense HW
    Diabetes Res Clin Pract; 2014 Oct; 106(1):73-80. PubMed ID: 25139631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissonance among treatment algorithms for hyperglycemia in type 2 diabetes: an egalitarian dialog.
    Giugliano D; Maiorino MI; Bellastella G; Esposito K
    J Endocrinol Invest; 2019 Feb; 42(2):237-242. PubMed ID: 29704235
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes and predictors for change to thiazolidinedione prescribing in UK primary care following the rosiglitazone safety warning.
    Hall GC; Smith HT; Curtis B; McMahon AD
    Int J Clin Pract; 2011 May; 65(5):586-91. PubMed ID: 21489082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey: perioperative diabetes medications and glucose control-time to re-examine management?
    Brown R; Siddiqui U; Paul J
    Can J Anaesth; 2019 May; 66(5):621-622. PubMed ID: 30726550
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study.
    Phillipov G; Phillips PJ
    Diabetes Care; 2006 Apr; 29(4):952-3; author reply 953. PubMed ID: 16602196
    [No Abstract]   [Full Text] [Related]  

  • 16. Approaches to treatment 1: How is type 2 diabetes actually treated?
    Bloomgarden ZT
    J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosiglitazone and cardiovascular risk.
    Brett AS
    N Engl J Med; 2007 Aug; 357(9):939; author reply 939-40. PubMed ID: 17806134
    [No Abstract]   [Full Text] [Related]  

  • 18. Variations in Metformin Prescribing for Type 2 Diabetes.
    Goldberg T; Kroehl ME; Suddarth KH; Trinkley KE
    J Am Board Fam Med; 2015; 28(6):777-84. PubMed ID: 26546654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IMPROVE study--a multinational, observational study in type 2 diabetes: data from the Polish cohort.
    Gumprecht J; Zurawska G; Wolnik B; Dzida G
    Endokrynol Pol; 2008; 59(6):460-6. PubMed ID: 19347809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin therapy: evolution and practice.
    Hirsch IB
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2():7-8. PubMed ID: 18407029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.